| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.4M | +126.5% |
| SG&A Expense | $15.8M | -10.9% |
| Operating Income | -$58.2M | -92.6% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$55.9M | -110.6% |
| Income Tax | $5K | -46.4% |
| Net Income | -$55.9M | -110.5% |
| EPS (Basic) | -$1.41 | -93.2% |
| EPS (Diluted) | -$1.41 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -91.4% |
| Short-term Investments | $19.9M | — |
| Current Assets | $27.1M | -61.7% |
| Total Assets | $28.3M | -61.1% |
| Current Liabilities | $8.2M | +89.1% |
| Total Liabilities | $8.3M | +79.7% |
| Stockholders' Equity | $20.0M | -70.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.1M | -70.6% |
| Capital Expenditures | $6K | -99.6% |
| Investing Cash Flow | -$19.5M | -7839.4% |
| Financing Cash Flow | $30K | -100.0% |
| Free Cash Flow | -$43.1M | -60.5% |
| -93.2% |